Overview of Dr. Hur
Dr. Chin Hur is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 22 years. He specializes in esophagus disease and gastrointestinal cancer.
Office
161 Fort Washington Avenue
New York, NY 10032
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Gastroenterology, 1999 - 2002
- Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
- Johns Hopkins University School of MedicineClass of 1995
Certifications & Licensure
- NY State Medical License 2018 - 2025
- MA State Medical License 1998 - 2019
Clinical Trials
- Decision Aid for Gastroesophageal Reflux Disease Management Start of enrollment: 2014 Jan 01
- Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps Start of enrollment: 2014 Jun 23
- Detection of Gastrointestinal Bleeding in Intensive Care Patients Via Biosensor Watch Start of enrollment: 2019 Mar 29
Publications & Presentations
PubMed
- 375 citationsTrends in esophageal adenocarcinoma incidence and mortalityChin Hur, Melecia C. Miller, Chung Yin Kong, Emily C. Dowling, Kevin J. Nattinger
Cancer. 2013-03-15 - 29 citationsThe Impact of Obesity on the Rise in Esophageal Adenocarcinoma Incidence: Estimates from a Disease Simulation ModelChung Yin Kong, Kevin J. Nattinger, Tristan J. Hayeck, Zehra B. Omer, Y. Claire Wang
Cancer Epidemiology, Biomarkers & Prevention. 2011-11-01 - 61 citationsCost-effectiveness of Bariatric Surgery in Adolescents With ObesityMatthew J. Klebanoff, Jagpreet Chhatwal, Jacob D. Nudel, Kathleen E. Corey, Lee M. Kaplan
JAMA Surgery. 2017-02-01
Journal Articles
- Survival Disparities by Race and Ethnicity in Early Esophageal CancerChin Hur, Ryan Nipp, Digestive Diseases and Sciences
Authored Content
- Mo1123 CRYOTHERAPY (TRUFREEZE™) VS. RADIO FREQUENCY ABLATION (BARRX™) FOR THE TREATMENT OF BARRETT’S ESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND/OR EARLY ADENOCARCINOMA: AD INTERIM RESULTS OF A NON-INFERIORITY RANDOMIZED CLINICAL TRIALMay 2018
- Mo1123 CRYOTHERAPY (TRUFREEZE™) VS. RADIO FREQUENCY ABLATION (BARRX™) FOR THE TREATMENT OF BARRETT’S ESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND/OR EARLY ADENOCARCINOMA: AD INTERIM RESULTS OF A NON-INFERIORITY RANDOMIZED CLINICAL TRIALMay 2018
Press Mentions
- Velocity Raises More Than $1.1 Million to End CancerNovember 28th, 2022
- Gastric Bypass Better for Type 2 DiabeticsFebruary 16th, 2022
- Gastric Bypass Most Cost-Effective for Severe Obesity, T2D?February 14th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Massachusetts Blue Care Elect PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Great West PPOHarvard Pilgrim HMO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Tufts Health Plan PPO
UniCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: